[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5052 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 5052

 To direct the Attorney General and the Secretary of Health and Human 
 Services to evaluate the effectiveness of grant programs that provide 
 grants for the primary purpose of providing assistance in addressing 
      problems pertaining to opioid abuse, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 26, 2016

Mr. McCarthy (for himself and Mr. Hoyer) introduced the following bill; 
  which was referred to the Committee on Energy and Commerce, and in 
    addition to the Committee on the Judiciary, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
 To direct the Attorney General and the Secretary of Health and Human 
 Services to evaluate the effectiveness of grant programs that provide 
 grants for the primary purpose of providing assistance in addressing 
      problems pertaining to opioid abuse, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Opioid Program Evaluation Act'' or 
the ``OPEN Act''.

SEC. 2. EVALUATION OF PERFORMANCE OF DEPARTMENT OF JUSTICE PROGRAM.

    (a) Evaluation of Justice Department Comprehensive Opioid Abuse 
Grant Program.--Not later than 5 years after the date of enactment of 
this Act, the Attorney General shall complete an evaluation of the 
effectiveness of the Comprehensive Opioid Abuse Grant Program under 
part LL of the Omnibus Crime Control and Safe Streets Act of 1968 
administered by the Department of Justice based upon the information 
reported under subsection (d) of this section.
    (b) Interim Evaluation.--Not later than 3 years after the date of 
enactment of this Act, the Attorney General shall complete an interim 
evaluation assessing the nature and extent of the incidence of opioid 
abuse and illegal opioid distribution in the United States.
    (c) Metrics and Outcomes for Evaluation.--Not later than 180 days 
after the date of enactment of this Act, the Attorney General shall 
identify outcomes that are to be achieved by activities funded by the 
Comprehensive Opioid Grant Abuse Program and the metrics by which the 
achievement of such outcomes shall be determined.
    (d) Metrics Data Collection.--The Attorney General shall require 
grantees under the Comprehensive Opioid Abuse Grant Program (and those 
receiving subawards under section 3021(b) of part LL of the Omnibus 
Crime Control and Safe Streets Act of 1968) to collect and annually 
report to the Department of Justice data based upon the metrics 
identified under subsection (c).
    (e) Publication of Data and Findings.--
            (1) Publication of outcomes and metrics.--The Attorney 
        General shall, not later than 30 days after completion of the 
        requirement under subsection (c), publish the outcomes and 
        metrics identified under that subsection.
            (2) Publication of evaluation.--In the case of the interim 
        evaluation under subsection (b), and the final evaluation under 
        subsection (a), the National Academy of Sciences shall, not 
        later than 90 days after such an evaluation is completed, 
        publish the results of such evaluation and issue a report on 
        such evaluation to the Committee on the Judiciary of the House 
        of Representatives and the Committee on the Judiciary of the 
        Senate. Such report shall also be published along with the data 
        used to make such evaluation.
    (f) Arrangement With the National Academy of Sciences.--For 
purposes of subsections (a), (b), and (c), the Attorney General shall 
enter into an arrangement with the National Academy of Sciences.

SEC. 3. EVALUATION OF PERFORMANCE OF DEPARTMENT OF HEALTH AND HUMAN 
              SERVICES PROGRAM.

    (a) Evaluation of Justice Department Comprehensive Opioid Abuse 
Grant Program.--Not later than 5 years after the date of enactment of 
this Act, the Secretary of Health and Human Services shall complete an 
evaluation of any program administered by the Secretary that provides 
grants for the primary purpose of providing assistance in addressing 
problems pertaining to opioid abuse based upon the information reported 
under subsection (d) of this section.
    (b) Interim Evaluation.--Not later than 3 years after the date of 
enactment of this Act, the Secretary shall complete an interim 
evaluation assessing the nature and extent of the incidence of opioid 
abuse and illegal opioid distribution in the United States.
    (c) Metrics and Outcomes for Evaluation.--Not later than 180 days 
after the date of enactment of this Act, the Secretary shall identify 
outcomes that are to be achieved by activities funded by the programs 
described in subsection (a) and the metrics by which the achievement of 
such outcomes shall be determined.
    (d) Metrics Data Collection.--The Secretary shall require grantees 
under the programs described in subsection (a) to collect and annually 
report to the Department of Health and Human Services data based upon 
the metrics identified under subsection (c).
    (e) Publication of Data and Findings.--
            (1) Publication of outcomes and metrics.--The Secretary 
        shall, not later than 30 days after completion of the 
        requirement under subsection (c), publish the outcomes and 
        metrics identified under that subsection.
            (2) Publication of evaluation.--In the case of the interim 
        evaluation under subsection (b), and each final evaluation 
        under subsection (a), the National Academy of Sciences shall, 
        not later than 90 days after such an evaluation is completed, 
        publish the results of such evaluation and issue a report on 
        such evaluation to the Committee on Energy and Commerce of the 
        House of Representatives and the Committee on Health, 
        Education, Labor, and Pensions of the Senate. Such report shall 
        also be published along with the data used to make such 
        evaluation.
    (f) Arrangement With the National Academy of Sciences.--For 
purposes of subsections (a), (b), and (c), the Secretary shall enter 
into an arrangement with the National Academy of Sciences.

SEC. 4. DEFINITION.

    In this Act, the term ``opioid'' has the meaning given the term 
``opiate'' in section 102 of the Controlled Substances Act (21 U.S.C. 
802).

SEC. 5. NO ADDITIONAL FUNDS AUTHORIZED.

    No additional funds are authorized to be appropriated to carry out 
this Act.
                                 <all>